//
David Kerbl - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Spontaneous coronary artery dissection
N/A
Sagar Vadhar - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Nephrology
Myocardial infarction
N/A
Haroon Zubair - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Spontaneous coronary artery dissection
N/A
Aayush Shah - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Myocardial infarction
N/A
Monique Oye - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Arrhythmogenic right ventricular cardiomyopathy
N/A
Raquel Amier - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
White matter hyperintensities
N/A
Ileana Torres-Burgos - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Infectious Diseases (ID)
Coronavirus disease
N/A
Kalyan Chitturi - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Myocardial infarction
Metoprolol
Ashley K. Russell - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Attention deficit hyperactivity disorder
amphetamine and dextroamphetamine
Michael Rofael - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Heart failure with reduced ejection fraction
Dobutamine
Amr Salama - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Blood/haematological Diseases
No obstructive coronary artery disease
Epinephrine
Karelys Burgos Irizarry - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Autoimmune (AI)
Acute Coronary Syndromes
Methylprednisolone
Kris Kumar - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Blood/haematological Diseases
Arrhythmia
Dobutamine
Muhammad Asim Shabbir - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Autoimmune (AI)
Myocardial infarction
Interleukin
Alexander E. Sullivan - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Pulmonary/Respiratory Diseases
Myocardial infarction
Durvalumab
Priya Patel - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Giant cell myocarditis
Doxycycline
Ali Azeem - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Autoimmune (AI)
No obstructive coronary artery disease
Norepinephrine bitartrate
Yetunde A. Fatade - American College of Cardiology (ACC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Infectious Diseases (ID)
Fulminant myocarditis
Dexamethasone
M. Serra Delgado - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022
Therapeutic Area
Disease
Drug/Treatment
Obstetrics/Gynecology
Female Sexual Dysfunction
EGCG
Ying Song - Transcatheter Cardiovascular Therapeutics (TCT) , 2022
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A